This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biomax Technologies Inc.. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Bruce M McManus: Innovator in Transplant Tissue Detection
Introduction
Bruce M McManus is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of medical technology, particularly in the detection of transplanted tissue rejection. His innovative approach combines various forms of light to enhance the accuracy of tissue analysis.
Latest Patents
Bruce M McManus holds a patent for "Methods and apparatus for detecting the rejection of transplanted tissue." This invention involves subjecting transplanted tissue to illumination with light to induce fluorescence. The light can be ultraviolet, visible, or infrared, and may be used in any combination. The induced fluorescence is then collected and analyzed, allowing for comparison with fluorescence obtained from a known, healthy tissue of the same type. This method also includes techniques for determining probe orientation and assessing the need for biopsy.
Career Highlights
Throughout his career, Bruce has been associated with Biomax Technologies Inc., where he has played a crucial role in advancing medical technologies. His work has focused on improving the methods used to monitor and assess the health of transplanted tissues, which is vital for patient care.
Collaborations
Bruce has collaborated with esteemed colleagues such as Haishan Zeng and Peter D Whitehead. Their combined expertise has contributed to the development of innovative solutions in the field of transplant medicine.
Conclusion
In summary, Bruce M McManus is a pioneering inventor whose work in detecting transplanted tissue rejection has the potential to significantly improve patient outcomes. His innovative methods and dedication to medical technology continue to make a lasting impact in the field.